Top Clinical Trials companies in Brazil by EBT Margin

This ranking features the top 2 Clinical Trials companies in Brazil ranked by EBT Margin, averaging a EBT Margin of -11.95%, for February 09, 2025.

Brazil

Clinical Trials
EBT Margin
#
Name
EBT Margin
 Reported Date
Stock Price
Change
 Price (30 days) Country
1
DASA3.SA

Diagnósticos da América S.A.

1

DASA3.SA
-6.99%
Dec. 31, 2023 USD 0.31 -3.93%

Brazil
2
AALR3.SA

Centro de Imagem Diagnósticos S.A.

2

AALR3.SA
-16.91%
Dec. 31, 2023 USD 1.75 -1.08%

Brazil
Frequently Asked Questions
  • Which Clinical Trials company in Brazil has the highest EBT Margin ?

    The Clinical Trials company in Brazil with the highest EBT Margin is Diagnósticos da América S.A. (São Paulo Stock Exchange: DASA3.SA) at -6.99%.

  • Which Clinical Trials company in Brazil has the lowest EBT Margin ?

    The Clinical Trials company in Brazil with the lowest EBT Margin is Centro de Imagem Diagnósticos S.A. (São Paulo Stock Exchange: AALR3.SA) at -16.91%.

SV Wall Street